CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Regenerex Pharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Regenerex Pharma Inc
5348 VEGAS DRIVE, SUITE 177
Phone: (305) 927-5191p:305 927-5191 LAS VEGAS, NV  89108  United States Ticker: RGPXRGPX
Business Summary
Regenerex Pharma, Inc. is engaged in the development and commercialization of advanced wound care healing products. The Company operates through three distinct proprietary technologies designed to address different wound care needs: Chronic Wound Closure Technology, Acute Wound Acceleration Technology and Contamination Control Technology. Chronic Wound Closure Technology is specifically designed for closing chronic wounds. Acute Wound Acceleration Technology is focused on accelerating closure of acute or surgical wounds. Contamination Control Technology addresses contamination issues across all wound types, including biofilm destruction. Its comprehensive Wound Closure System and protocols effectively treat a broad spectrum of wounds, including diabetic ulcers, pressure ulcers, venous ulcers, burns, and surgical wounds. Its proprietary active ingredient, QBx, addresses a critical issue in wound healing by down-regulating the production of specific proteases and matrix metalloproteases.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20253/31/2025YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
7389 Business services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Gregory P.Pilant 67
Chief Financial Officer Kenneth W.Perry 3/31/2025 3/31/2025
Chief Operating Officer TroyThuet 61
Treasurer, Secretary, Director LeeOri 47 12/6/2024
Director J. KennethHazen 12/6/2024 12/6/2024

Business Names
Business Name
Creenergy Corporation
Online Original Inc
ONLINE ORIGINALS, INC
Online Originals, Inc.
PEPT
RGPX

General Information
Outstanding Shares: 282,372,310 (As of 11/17/2025)
Shareholders: 297
Stock Exchange: OTC
Federal Tax Id: 980479983


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 6, 2025